Clover Health Investments Earnings & Forecasts

Clover Health Investments (CLOV) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Aug 5, 2026	$0.05	$0.04	25.0 %
Q1	May 6, 2026	$0.05	$0.06	-16.7 %
Q4	Feb 26, 2026	$-0.10	$-0.07	-42.9 %
Q3	Nov 4, 2025	$-0.05	$-0.01	-400.0 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Aug 5, 2026	$743.17M	$728.27M	2.05 %
Q1	May 6, 2026	$749.20M	$713.48M	5.01 %
Q4	Feb 26, 2026	$487.71M	$469.23M	3.94 %
Q3	Nov 4, 2025	$496.65M	$472.81M	5.04 %

Clover Health Investments Guidance

Clover Health Investments (CLOV)는 8월 5, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $2.92B - $3B 범위로 예상했습니다.

이전 가이던스와 비교하여 Clover Health Investments는 매출 전망치를 이전 범위인 상향 조정됨에서 $2.81B - $2.92B로 상향 조정했습니다.

Clover Health Investments은 11과 11월 7, 2022 사이에 8월 5, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 3 times and lowered it 1 time, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.04	$0.06	$-0.07	$-0.01
Actual	$0.05	$0.05	$-0.10	$-0.05
Surprise	+25.0%	-16.7%	-42.9%	-400.0%
Revenue
Estimate	$728.3M	$713.5M	$469.2M	$472.8M
Actual	$743.2M	$749.2M	$487.7M	$496.6M
Surprise	+2.05%	+5.01%	+3.94%	+5.04%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E
Earnings Per Share (Non-GAAP)
Consensus	$-0.02	$-0.03	$0.05
Revenue
Consensus	$738.2M	$723.5M	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Clover Health Investments Raises FY2026 Sales Guidance from $2.810B-$2.920B to $2.920B-$3.000B vs $2.910B Est

Clover Health Investments (NASDAQ:CLOV) raises FY2026 sales outlook from $2.810 billion-$2.920 billion to $2.920 billion-$3.000 billion vs $2.910 billion estimate.

Benzinga Newsdesk

PRO
Clover Health Investments Q2 EPS $0.05 Beats $0.03 Estimate, Sales $743.167M Beat $728.267M Estimate

Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 350 percent increase over losses of $(0.02) per share

Benzinga Newsdesk

Jim Cramer Won't Recommend Mortgage Stocks Because 'I Never Know What They Really Own' — But He Loves Intel's 'Burgeoning Packaging Division'

Cramer criticizes Clover Health's quarterly results, recommends Amkor for semiconductor packaging, and expresses caution over mortgage stocks.

Avi Kapoor

Clover Health Investments Corp